SARS-CoV-2

Virus that causes COVID-19

SARS-CoV-2 ▸ Facts ▸ Comments ▸ News ▸ Videos

Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is a strain of coronavirus that causes COVID-19, the respiratory illness responsible for the COVID-19 pandemic. The virus previously had the provisional name 2019 novel coronavirus (2019-nCoV), and has also been called human coronavirus 2019. First identified in the city of Wuhan, Hubei, China, the World Health Organization designated the outbreak a public health emergency of international concern from January 30, 2020, to May 5, 2023. SARS‑CoV‑2 is a positive-sense single-stranded RNA virus that is contagious in humans.

0 shares	Share Tweet Save Post Send

You Might Like

'Virus has reemerged..' Experts warn India to be prepared for another COVID outbreak, this variant is... The latest update from the World Health Organization (WHO) showed that between June 24 and July 21, an average of 17,358 Covid specimens were tested for SARS-CoV-2 every week across 85 countries. DNA - Published on August 30, 2024
Scientists in Bengaluru discover means to tackle Covid-19 variants Scientists discovered a way to fight current and future variants of SARS-CoV2 by boosting the body's antiviral defenses. They focused on enhancing antimicrobial peptides (AMPs) and found that higher.. IndiaTimes - Published on January 24, 2024
All Covid strains given to Bharat Biotech for a universal jab: Centre Indian Council of Medical Research (ICMR) has transferred all existing strains of variants of concern of SARS-CoV-2 - virus that causes Covid-19 - to Bharat Biotech Ltd for developing a universal Covid.. IndiaTimes - Published on December 19, 2023

Indian scientists uncover hidden reservoir of SARS-CoV-2 in body cells, paving way for improved Covid-19 diagnosis IndiaTimes - Published on December 13, 2023
This flu season, H3N2 trumps swine flu, Covid In the battleground of viruses, a clear dominator this monsoon has been the influenza A subtype H3N2 that has surpassed two recent pandemic viruses, H1N1 (swine flu) and SARS-CoV-2. Co-circulating with.. IndiaTimes - Published on July 29, 2023
Evidence of viral resistance to Covid-19 drug Paxlovid found A new research provided evidence of viral resistance to Paxlovid among SARS-CoV-2 variants currently circulating globally, indicating that this stand-alone drug could soon become less effective in.. IndiaTimes - Published on March 30, 2023

Enhanced recombination is a shot in the arm for SARS-CoV-2: IISc study IndiaTimes - Published on March 20, 2023
‘India detected 300 Omicron sub-lineages, none settled’ Between December 24 and January 3, the health ministry sources said, 124 people arriving to India from abroad were found positive for Covid-19. The sources said 11 variants of SARS-CoV-2 were.. IndiaTimes - Published on January 8, 2023
Covid positivity at 0.1% in last 24 hours: Govt The sources said 11 variants of SARS-CoV-2, the virus that causes Covid-19, were identified in Whole Genome Sequencing (WSG) carried out on the samples of 40 passengers who were found positive. IndiaTimes - Published on January 7, 2023
India-made drug shows promise in treating Covid heart damage A drug developed by the Defence Research and Development Organisation (DRDO) may reverse the heart damage caused by a protein in the SARS-CoV-2 virus, a study conducted in fruit flies and mice has.. IndiaTimes - Published on November 8, 2022

Main Omicron subvariant now mutating further: Insacog BA.2.75 has spawned what has been designated as BA.2.75.2, which recently drew the attention of experts tracking mutations in SARS-CoV-2. Yunlong Richard Cao, an immunologist at Peking University,.. IndiaTimes - Published on September 10, 2022
BA.2.38 causing just mild illness: Study Omicron sub-variant BA.2's offspring, BA.2.38, may be causing a spike in Maharashtra and other parts of India, but the illness it is causing is self-limiting and almost comparable with common cold-like.. IndiaTimes - Published on June 20, 2022
Anocovax: India's first Covid vaccine for animals launched The immunity induced by Anocovax neutralises both Delta and Omicron variants of SARS-CoV-2, the Indian Council of Agricultural Research (ICAR) said. DNA - Published on June 9, 2022	Are 3 doses of Covid-19 vaccine better than 2? Study says THIS During study period, 197,535 (6.3 per cent) patients were infected with SARS-CoV-2, and of those, 15,786 (8 per cent) were admitted to the hospital. DNA - Published on February 14, 2022
Omicron now dominant variant of SARS-CoV-2 in country: Government IndiaTimes - Published on February 4, 2022